Degradation of type I collagen by Porphyromonas gingivalis was monitored by fluorogenic, sodium dodecyl sulfate^polyacrylamide gel electrophoresis (SDS^PAGE), and growth assays. All three assays showed that inactivation of both the rgpA and rgpB genes was necessary to completely eliminate the capacity of P. gingivalis to cleave type I collagen. Leupeptin, an Arg-gingipain-specific protease inhibitor, almost completely inhibited collagen degradation by P. gingivalis cells whereas cathepsin B inhibitor II, a Lys-gingipain inhibitor, did not. A purified preparation of Arg-gingipains A and B hydrolyzed gelatin but did not cleave type I collagen, suggesting that the enzymes must be attached to the cell surface to exert collagenase activity. A number of substances used as adjuncts in periodontal therapy were also tested for their capacity to inhibit collagenase activity of P. gingivalis. Tetracycline, doxycycline, and chlorhexidine strongly inhibited collagenase activity.
Introduction
Periodontitis, a chronic in£ammatory disorder characterized by a signi¢cant loss of connective tissue attachment, is initiated by an overgrowth of speci¢c Gram-negative bacteria [1] . Type I collagen is the predominant constituent of periodontal tissues and is composed of three parallel polypeptide chains rich in the triplet sequence Gly-X-Y, where X and Y are often proline and hydroxyproline, respectively [2] . The triple helix is stabilized by interchain hydrogen bonding and inter-and intramolecular cross-linking that make the molecule highly resistant to hydrolysis by proteolytic enzymes.
Porphyromonas gingivalis is a key etiologic agent of chronic periodontitis [3] . It produces a variety of virulence factors, including the cysteine proteinases Arg-and Lysgingipains [4] . Arg-gingipain activity is coded for by two genes (rgpA and rgpB), whereas Lys-gingipain activity is coded for by one gene (kgp) [5] . Gingipains are both extracellular and cell-bound and have a wide activity spectrum [4] . A number of ¢ndings suggest that these proteinases play critical roles in host colonization, perturbation of the immune system, and tissue destruction during periodontitis [4] . Although numerous studies have been published on the collagenase activity of P. gingivalis [6^10], it is not yet clear whether the degradation of type I collagen results from the action of a speci¢c collagenase or Arg-and Lys-gingipains, alone or in combination. Unclear, contradictory results are mostly related to the use of non-speci¢c collagenase assays. The primary aim of the present study was to investigate the nature of the collagenase activity of P. gingivalis using gingipain-de¢cient mutants, puri¢ed gingipains, and selective proteinase inhibitors. A number of substances used as adjuncts in periodontal therapy were also evaluated for their capacity to inhibit the collagenase activity of P. gingivalis.
Materials and methods
P. gingivalis ATCC 33277 and ¢ve gingipain-de¢cient mutants generated by allelic replacement mutagenesis or suicide plasmid integration (KDP129, a kgp (Lys-gingi-pain) mutant ; KDP131, a rgpA (Arg-gingipain A) mutant; KDP132, a rgpB (Arg-gingipain B) mutant; KDP112, a rgpA rgpB (Arg-gingipains A and B) double mutant; and KDP128, a kgp rgpA rgpB (Lys-gingipain, Arg-gingipains A and B) triple mutant) were used [11, 12] . Cultures were grown in Todd Hewitt broth (Difco Laboratories, Detroit, MI, USA) supplemented with hemin (10 Wg ml 31 ) and vitamin K (1 Wg ml 31 ) (THBHK). Antibiotics were used to maintain selective pressure and prevent the appearance of revertants among the following mutants: KDP112 (tetracycline at 0.36 Wg ml 31 and erythromycin at 1 Wg ml 31 ), KDP131 (erythromycin at 1 Wg ml 31 ), and KDP132 (tetracycline at 0.36 Wg ml 31 ). To avoid possible side e¡ects, antibiotics were not added to the broth media used for preparing the cells used in the experiments described below. All cultures were incubated at 37 ‡C in an anaerobic chamber (N 2 :H 2 :CO 2 /80:10:10). The phenotypes of the mutants were con¢rmed prior to the experiments by testing their ability to cleave the chromogenic substrates for Arg-gingipain (benzoyl-Arg-p-nitroanilide) and Lys-gingipain (N-p-tosyl-Gly-Pro-Lys-p-nitroanilide) as described previously [13] .
Mutant KDP129 was used to prepare a puri¢ed fraction containing both Arg-gingipains A and B whereas the mutant KDP112 was used to isolate Lys-gingipain. The use of these mutants facilitated the puri¢cation of the gingipains, which are di⁄cult to separate from one another. Gingipains were puri¢ed from cell envelope extracts by a⁄nity chromatography on arginine Sepharose 4B (Amersham Pharmacia Biotech, Baie d'Urfe ¤, QC, Canada) as previously described [14] . Arg-and Lys-gingipain activities were quanti¢ed using benzoyl-Arg-p-nitroanilide and N-p-tosyl-Gly-Pro-Lys-p-nitroanilide, respectively. One unit of enzyme activity was de¢ned as the amount required to release 1 nM of p-nitroaniline per h.
Degradation of type I collagen by P. gingivalis ATCC 33277 and the mutants de¢cient in Arg-and/or Lys-gingipains was ¢rst evaluated using a £uorogenic assay. The reaction mixtures contained 20 Wl of bacterial cells (OD 660 = 1.5 in 50 mM phosphate-bu¡ered saline (PBS) pH 7.2), 10 Wl of self-quenched bovine skin type I collagen labeled with £uorescein (D-12060; Molecular Probes, Eugene, OR, USA; 1 mg ml 31 ), 137 Wl of PBS, and 33 Wl of 30 mM dithiothreitol. The reaction mixtures were incubated for 2 h in the dark at 25 ‡C. Cells were then removed by centrifugation (8000Ug for 15 min) and the £uores-cence of the supernatants was measured using a £uorom-eter at excitation and emission wavelengths of 490 and 520 nm, respectively. The speci¢city of the assay was monitored using bovine pancreatic trypsin, bovine pancreatic chymotrypsin, and Clostridium histolyticum collagenase (0.4 units ml 31 ). Assays were repeated three to four times and the means þ standard deviations were calculated. The e¡ect of protease inhibitors (leupeptin, cathepsin B inhibitor II) and antimicrobials (chlorhexidine, tetracycline, doxycycline, metronidazole, penicillin G, and erythromycin), all at 1 mM, on the degradation of type I collagen by P. gingivalis was determined using the £uorogenic assay. The collagenase activity of P. gingivalis was also evaluated by sodium dodecyl sulfate^polyacrylamide gel electrophoresis (SDS^PAGE) and Coomassie blue staining. Assay mixtures contained 20 Wl of bacterial cells (OD 660 = 1.5 in PBS), 30 Wl of soluble type I bovine skin collagen (Sigma Chemical Co., St. Louis, MO, USA; 2 mg ml 31 ) and 10 Wl of 60 mM dithiothreitol. Following a 4 h incubation at 25 ‡C, the assay mixtures were heated for 15 min at 70 ‡C to inactivate the enzymes, boiled in electrophoresis sample bu¡er, and run on SDS/7.5% polyacrylamide gels. Migrated proteins were stained with Coomassie brilliant blue R-250. Degradation of the soluble type I bovine skin collagen by the puri¢ed preparations of Arg-gingipains A/ B and Lys-gingipain was also evaluated by SDS^PAGE and autoradiography. Enzymes (12.5 Wl; 312 units ml 31 ) were incubated for 18 h at 25 ‡C or 37 ‡C in PBS containing 30 mM dithiothreitol (7.5 Wl) and 14 C-labeled type I collagen (15 Wl; 1 mg ml 31 ), either native or denatured by heating for 15 min at 50 ‡C. Collagen labeling was performed as previously described [8] . The assay mixtures were then heated at 70 ‡C for 30 min to inactivate the enzymes, boiled in electrophoresis sample bu¡er, and subjected to SDS^PAGE using 10% slab gels. Proteins were ¢xed in 20% (v/v) methanol:10% (v/v) acetic acid and auto£uorographic ampli¢cation was performed using intensify solutions (NEN Research Products, DuPont, Boston, MA, USA) and Kodak X-OMAT ¢lm for 5 days at 380 ‡C. Collagenase activity was also assessed using a semi-quantitative growth assay speci¢c for collagenaseproducing bacteria [8] . Insoluble bovine skin type I collagen (Sigma ; 10 mg) was sterilized by autoclaving. Sterile pre-reduced THBHK medium (10 ml) was added to collagen prior to inoculation with P. gingivalis. Degradation of the collagen that had settled to the bottom of the tubes was evaluated visually each day for 4 days using the following scale: 3, no collagen degradation ; +, 25^50% degradation; ++, 50^75% degradation; +++, s 75% collagen degradation.
Results
All three assays revealed extensive degradation of type I collagen by P. gingivalis ATCC 33277 (Fig. 1, Tables 1  and 2 ). The £uorescein-labeled type I collagen assay was very speci¢c since only negligible degradation was observed with trypsin and chymotrypsin while the C. histolyticum collagenase extensively degraded the collagen (data not shown). This assay showed that inactivation of either rgpA or rgpB only slightly reduced (23 and 18%, respectively) collagenase activity (Table 1) . On the other hand, inactivation of both rgpA and rgpB resulted in an almost complete inhibition of collagenase activity. The lack of Lys-gingipain activity had little e¡ect (11% inhibition) on collagenase activity. Evaluation of collagen degradation by SDS^PAGE and Coomassie blue staining (Fig. 1) supported the results obtained with the £uorogenic assay. The cleavage pattern observed with P. gingivalis ATCC 33277 indicated that collagen was degraded into low molecular mass peptides.
Since the wild-type strain and gingipain-de¢cient mutants of P. gingivalis ATCC 33277 grew to a similar extent in the THBHK medium containing insoluble collagen (data not shown), the di¡erences in collagen degradation were not caused by variations in cell density. Extensive collagen degradation ( s 75%) was observed with P. gingivalis ATCC 33277 and the mutants de¢cient in either Arggingipain A or B ( Table 2 ). The Lys-gingipain mutant (KDP129) degraded 50^75% of the insoluble collagen. KDP112 (rgpA rgpB) degraded collagen weakly and KDP128 (rgpA rgpB kgp), not at all.
The contribution of P. gingivalis gingipains to the degradation of type I collagen was further investigated with the £uorogenic assay using speci¢c Arg-gingipain (leupeptin) and Lys-gingipain (cathepsin B inhibitor II) inhibitors [13] . Leupeptin completely inhibited collagen degradation by P. gingivalis while cathepsin B inhibitor II was a poor inhibitor (Table 3) . Puri¢ed gingipain preparations were tested by SDS^PAGE and autoradiography for the capacity to degrade type I collagen (Fig. 2) . Collagen denatured by a 15 min heat treatment at 50 ‡C was degraded by preparations of Arg-gingipains A/B and Lys-gingipain, at both 25 ‡C and 37 ‡C. On the other hand, degradation of native collagen occurred only at 37 ‡C. No degradation was observed at 25 ‡C, even with a mixture of Arg-gingipains A/B and Lys-gingipain. The cell suspension of P. gingivalis ATCC 33277 degraded the radiolabeled native collagen at both 25 ‡C and 37 ‡C (data not shown).
Lastly, the £uorogenic assay was used to evaluate the capacity of the antimicrobial agents to inhibit the collagenase activity of P. gingivalis ATCC 33277. Chlorhexidine and doxycycline inhibited collagen degradation by over 90% while tetracycline inhibited degradation to a lesser degree (37%) ( Table 2) . Metronidazole, penicillin G, and erythromycin had little or no e¡ect.
Discussion
A number of human pathogens, including P. gingivalis, produce collagenases [15] . Monitoring collagenase activity requires an assay using native collagen. Since collagen can be denatured by mild heating and certain salts, selecting a Degradation of collagen that had settled to the bottom of the tube was evaluated visually each day for 4 days using the following scale : 3, no collagen degradation ; +, 25^50% degradation; ++, 50^75% degradation; +++, s 75% degradation.
an appropriate and reliable assay is of utmost importance if the goal is to monitor collagenase and not gelatinase activity. Available data on the collagenase activity of P. gingivalis are unclear and often contradictory. This is mostly due to the use of non-speci¢c collagenase assays (incubation temperature, substrate). The enzyme responsible for the degradation of native type I collagen is poorly characterized. Kato et al. [7] isolated the prtC gene, which codes for a P. gingivalis collagenase with an apparent molecular mass of 70 kDa. They reported that reducing agents do not enhance enzyme activity [7] . However, the prtC product is not responsible for most P. gingivalis collagenase activity since a mutant defective in this gene still possesses a strong collagen-degrading capacity [16] .
In this study, we used three highly speci¢c assays to monitor the collagenase activity of P. gingivalis. We also used an incubation temperature of 25 ‡C to avoid the denaturation of collagen into gelatin. Our results indicate that gene inactivation of both Arg-gingipains A and B completely eliminated the capacity of P. gingivalis to cleave native type I collagen, suggesting that these two enzymes are responsible for the collagenase activity of P. gingivalis. On the other hand, Lys-gingipain appeared to have little or no involvement in the degradation of type I collagen by P. gingivalis. RgpA, RgpB, and/or Kgp may also be involved in processing another protease or other proteases with collagenase activity, which would also explain the inability of mutants KDP112 (rgpA, rgpB) and KDP128 (rgpA, rgpB, kgp) to degrade collagen. However, the results obtained by including leupeptin in the £uoro-genic assay support the notion that Arg-gingipain is entirely responsible for the collagenase activity of P. gingivalis ATCC 33277. The collagenase activity expressed by the Arg-gingipains seems to require that the enzymes be attached to the bacterial cell surface since no degradation of soluble native collagen occurred with a puri¢ed preparation containing both Arg-gingipains A and B. This suggests that the enzyme might require a speci¢c conformational arrangement to degrade native collagen. The absence of collagenase activity in the Arg-gingipain preparation may also be due to the fact that (i) another protease is required to work in concert with the Arg-gingipains to degrade collagen, or (ii) the Arg-gingipains do not degrade collagen but are involved in processing another protease or other proteases with collagenase activity. Tokuda et al. [10] recently reported that the Arg-gingipain A coded for by the rgpA gene is responsible for most of the degradation of collagen ¢brils by P. gingivalis. In our study, strain variations (381 vs. ATCC 33277) may explain why both Arg-gingipains A and B appeared to possess strong collagenase activity. Strain variations were also reported to be important in ¢mbriation since the ATCC 33277 rgpA mutant appears to be normally ¢mbriated [17] while the 381 rgpA mutant lacks visible ¢mbriae [10] . However, Tokuda et al. [10] showed that puri¢ed Table 3 Capacity of several substances to inhibit the collagenase activity of P. gingivalis ATCC 33277 evaluated using the £uorogenic assay RgpA, unlike the cell-associated form, does not possess collagenase activity, which is in agreement with our results. Lastly, tetracycline, doxycycline, and chlorhexidine strongly inhibited the collagenase activity of P. gingivalis, which may point to an additional therapeutic e¡ect for these antibiotics. Inhibition of host-derived collagenases by chlorhexidine as well as antibiotics of the tetracycline family has been previously reported [18^20] .
